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Abstract
Background: Mental Retardation is a common heterogeneous neurodevelopment condition,
which causes are still largely elusive. It has been suggested that half of the phenotypic variation of
intelligence is explained by genetic variation. And genetic or inherited factors indeed account for
most of the cases of mental retardation with an identifiable cause. However, only a few autosomal
genes have been mapped and identified to date. In this report, the genetic causes for an apparently
recessive form of mental retardation, in a large nordern swedish pedigree, are investigated.
Methods: After extensive evaluation of the patients, which ruled out recognizable patterns of
malformation and excluded known causes of MR, a comprehensive genome-wide linkage analysis,
with 500 microsatellite markers, was performed in 24 members of this family. Additionally, a
genome-wide copy number analysis, using an affimetrix 250 K SNP chip, was performed in this
pedigree.
Results: No significant LOD score was found with either parametric and non-parametric linkage
analysis. The highest scores are located at chromosomes 13, 15 and 17. Genome-wide copy
number analysis identified no clear cause for the disorder; but rather, several variants were present
in the family members, irrespective of their affected status.
Conclusion:  These results suggest that mental retardation in this family, unlikely what was
expected, has a heterogeneous aetiology; and that several lower effect genes variants might be
involved. To demonstrate such effects, our family may be too small. This study also indicates that
the ascertainment of the cause of MR may be challenging, and that a complex aetiology may be
present even within a pedigree, constituting an additional obstacle for genetic counselling. Variants
in genes involved in molecular mechanisms of cellular plasticity, in genes involved in the
development of underlying neural architectures, and in genes involved in neurodevelopment and in
the ongoing function of terminally differentiated neurons may underlie the phenotypic variation of
intelligence and explain instances of intellectual impairment.
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Background
Mental retardation (MR) is characterized by severe limita-
tions in intellectual functioning and in adaptive behav-
iour, as expressed in conceptual, social and practical
adaptive skills and with onset before the age of 18 [1,2].
This disability originates as a consequence of abnormal
brain development and impaired cognition. MR, as classi-
fied by the DSM-IV, affects approximately 2–3% of chil-
dren and young adults, being one of the frequent
neuropsychiatric disorders [1,2]. Non-syndromic mental
retardation (NSMR) is the diagnosis of exclusion in men-
tally retarded individuals who do not have dimorphic fea-
tures, or neurological abnormalities.
We are far from understanding the biology of MR, due to
its extraordinary heterogeneity. Despite common, its
causes remain unexplained for more than 50% of
patients, limiting the efficiency of genetic counselling,
detection of carriers, prenatal diagnosis in the affected
families and constituting one of the most important unre-
solved problems in clinical genetics [3].
In the cases in which the aetiology is known, genetic or
inherited aetiologies are implicated in a considerable frac-
tion of the cases [3,4]. These include chromosomal rear-
rangements that result mainly in pathogenic gene dosage
effect, alteration of the imprinting in specific genes or
genomic regions and dysfunction of single genes. A recent
analysis of the Online Mendelian Inheritance in Man
(OMIM) database indicated that about 280 unrelated
chromosomal aberrations and single-gene mutations
involve or cause mental retardation [4]. These genes are
distributed over a broad range of functions, including
enzymes, mediators of signal transduction and transcrip-
tion regulation, binding proteins, and transporters [4-7].
Numerous aspects of neuronal differentiation and synap-
tic plasticity, synaptic vesicle cycling and gene expression
regulation are considered to be important in the aetiology
of MR. Hundreds more MR genes remain to be identified.
A monogenic mode of transmission may account for
nearly one-fourth of these cases [7-9]. However only a few
autosomal genes have been mapped and identified to
date: The PRSS12 gene on chromosome 4q25-q26 in one
Algerian family (MRT1; MIM #249500), the CRBN gene
on 3p26.2 in one large American family with German
ancestry (MRT2A; MIM #607417), the CC2D1A gene on
19p13.12 in one large Arab-Israeli family (MRT3; MIM
#608443) and the ionotropic glutamate receptor 6 gene
(GRIK2; MIM # 138244) on 6q16.1-q21, which is associ-
ated with autosomal recessive mental retardation in a
large, consanguineous Iranian family [10-13]. The exist-
ence of large family pedigrees with non-syndromic, auto-
somal forms of MR can be important tools to the use of
genetic linkage analysis to identify causative genes and
may thus shed light on the biology of MR.
Autosomal recessive diseases are common in isolated
populations, mostly as a result of the high rate of consan-
guinity [14]. In this report, the genetic causes for an appar-
ently recessive form of non-syndromic mental
retardation, in a large nordern swedish pedigree, are
investigated. This study is a follow up of a prevoius report
by Gustavson K-H, et al, 1986 [15].
Methods
An Ethics Committee at the Karolinska Institute has
approved the protocols for this research project. And it
conforms to the provisions of the Declaration of Helsinki
in 1995 (as revised in Edinburgh 2000). Subject, and/or
their parents, gave informed consent and patient anonym-
ity has been preserved.
Description of the family and the geographic region
Patient material was initially collected between, 1946 and
1983, from a large family living in a North Swedish iso-
late. This area, of about 5000 Km2, is located at the Swed-
ish-Finnish border, in the fork of 2 large rivers, the
Muonio and the Torne, and includes 3 parishes: Pajala,
Muonionalusta and Junosuando. Only after the end of the
16th century, was some settlements registered by north
Finnish families. By the beginning of the 19th century, the
population was about 2,000, many of them related to the
first settlers. The particular geography and demography
contributed to the creation of an isolate, where a large
number of consanguineous marriages occurred.
The family
The present study included 24 individuals from a large
family, partially overlapping in more distant generations.
The pedigree can be seen in figure 1, and the studied indi-
viduals are the ones marked with a numeric or alfa-
numeric code, and includes 9 mild mentally retarded
individuals (301, 304, 322, u1, u2, 319, u3, 829 and 830),
one individual affected with schizophrenia and mild
mental retardation (329), 13 non affected individuals
(302, 303, 307, 323, 324, 309, 321, 330, 310, 311, 320,
326, 328) and one individual with schizophrenia (327).
Individual 325 was not included due to insuficient phe-
notypic and biological data. Extensive clinical, biochemi-
cal, imaging and genetic examinations have been carried
out. The clinical evaluation was extensive but inconsist-
ent. The following paragraphs present a concise character-
ization of the patients.
History/Physical examination
All the mentally retarded individualswere physically
examined by one of the authors, K-H G, specialist in pedi-
atrics and clinical genetics. The MR patients presented noBMC Medical Genetics 2008, 9:6 http://www.biomedcentral.com/1471-2350/9/6
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major malformation and no recognizable pattern of mal-
formations was identified. Non-consistent minor signs
were found in some individuals; eight of the physically
examined patients were short and had a picnic, but not
obese, body type. Psychological evaluation revealed an
overall low level of intelligence (IQ around 50), with
lower ability of logical thinking. Attention deficits are
present and characterized by a focus towards an apparent
part of an event and to an episode's different parts rather
than the correlation between them. Among themselves
they have reached diverse skills spatial and perceptually.
Otherwise, the patients are outgoing and with good social
interaction.
Cytogenetics/Molecular cytogenetics
Five of the patients underwent karotyping and subtelom-
eric rearrangement analysis at the Clinical Genetic Depart-
ments of the Uppsala University Hospital and of the
Karolinska Hospital. Major chromosomic inbalances were
ruled out by QM, R and C-banding karyotyping. Subtelo-
meric cryptic rearrangements by fluorescence in situ
hybridization (FISH) probes from the subtelomeric
regions of all chromosome arms were not found [16].
Repeat expansion detection (RED) was performed, and no
expanded trinucleotide repeat was found [17]. Screening
for Fragile X was performed by standard procedures in the
index patient, and no abnormality was found.
Metabolic workup
Despite the absence of specific signs of a metabolic disor-
der, a metabolic workup was performed, including the
general assessment of acid/base balance, plasma and
urine amino and organic acid studies, thyroid screening
tests, lysosomal enzyme analysis, plasma and urine carni-
tine analyses, plasma very long chain fatty acids, was per-
formed showing no consistent abnormality. Three
patients presented higher levels of hydroxyhippuric acid
in urine.
Neuroimaging studies
Four of the patients were admitted to the Department of
Psychiatry, St. Göran's Hospital, Stockholm. CT scans of
Northern Swedish Pedigree Figure 1
Northern Swedish Pedigree. The study includes 24 individuals from a large family, partially overlapping in more distant gen-
erations, including 9 mild mentally retarded individuals (301, 304, 322, u1, u2, 319, u3, 829 and 830), one individual affected 
with schizophrenia and mild mental retardation (329), 13 non affected individuals (302, 303, 307, 323, 324, 309, 321, 330, 310, 
311, 320, 326, 328) and one individual with schizophrenia (327). Individual 325 was not included due to insuficient phenotypic 
and biological data.BMC Medical Genetics 2008, 9:6 http://www.biomedcentral.com/1471-2350/9/6
Page 4 of 9
(page number not for citation purposes)
the brain showed widened subarachnoidal space over cer-
ebellum in one patient, general brain atrophy in one other
case, widened ventricular system in another case; the three
cases presented structural abnormalities indicative of
brain atrophy.
Experimental setup
Peripheral blood samples were collected and the genomic
DNA was extracted by standard procedures. Whole-
genome screening was performed on the available 24 fam-
ily members, by typing 500 evenly distributed polymor-
phic microsatellite markers. The reactions were conducted
by deCODE Genetics in Reykjavik, Iceland, upon delivery
of the DNA samples. In the present framework marker set,
the average spacing between markers was approximately
10 cM.
Before the statistical analysis, allele frequencies were esti-
mated from all genotyped individuals using the
zGenStat1.126 program (H. Zazzi, unpubl. data). All gen-
otyped markers were checked for Mendelian incompati-
bilities using zGenstat1.126 program and with PedCheck
program [18]. Either the incompatibility was resolved
unambiguously, or individuals were excluded from the
linkage analysis at that locus. To identify markers with
allele dropout or other problems, the expected number of
homozygous individuals was calculated based on the esti-
mated allele frequencies and compared with the observed
numbers of homozygotes using the Pearson chi-squared
test with zGenStat1.126 software (H. Zazzi, unpubl. data).
Any marker deviating significantly from expected
homozygosity frequency (P < 0.001) was removed from
the analysis. This resulted in the removal of data from two
markers. An estimate contribution of affected and unaf-
fected offspring to the LOD score revealed a predicted
LOD of 2.7 to 3.9 in a recessive model, and 5.7 to 7.9 in a
dominant model, depending on the penetrance.
Single point and multipoint linkage analysis, for both lin-
ear and exponential models, was initially performed using
non-parametric affected relative-pair-based methods. The
linkage analysis, including allele sharing LOD scores, NPL
scores and haplotyping, were obtained using the program
ALLEGRO version 1.2. using the Allegro software [19].
Non-parametric P-values were interpreted according to
Lander and Kruglyak [20], as summarized by Nyholt [21].
For multi-point linkage analysis, the LOD ≥ 2.19 corre-
sponding to a P-value of < 7.4 × 104 is regarded as sugges-
tive linkage.
Additionally, we maximized the LOD scores with respect
to the disease model parameters by performing
multipoint parametric linkage analysis and haplotype
analysis with the program GENEHUNTER-MODSCORE
[22] with standard criteria. This software explores the dis-
ease-model parameter space in an efficient way. It can
handle autosomal or pseudoautosomal loci. It is also
capable of taking imprinting into account in a parametric
linkage analysis.
SimWalk2 version 2.83 [23] was then used to carry out
multipoint parametric linkage analysis and haplotype
analysis. This program can analyze large pedigrees by
using the Markov chain Monte Carlo and simulated
annealing algorithms to compute location scores which
are directly comparable to multipoint LOD scores and are
presented in log10 units. Single point analysis, using the
MLINK program [24], was performed with the linked hap-
lotype as disease allele and any other haplotype as wild
type allele. Autosomal dominant and autosomal recessive
modes of inheritance were assumed with 80% penetrance
and phenocopy rates of 1–10%. Marker positions were
obtained from the Marshfield and the Généthon genetic
maps [25].
Copy number analysis was performed in the individuals
301, 304, 322, u1, u2, 319, u3, 829, 830, 302, 303, 307,
323, 324, 309, 321, 330, 310 and 311. The individuals
320, 326, 327 and 328 were not included as they were not
considered to be very informative. For this procedure we
used a high-density oligonucleotide microarrays devel-
oped by Affymetrix. Array experiments were performed
according to the Affymetrix GeneChip Mapping 250 K
array standard protocol (Affymetrix Inc., Santa Clara, CA,
USA) at the Uppsala Array Platform, Sweden. We
obtained a call rate of approximately 100%. The physical
position of all SNPs was mapped according to the latest
genome assembly at the UCSC Genome Browser. The
analysis was performed with the Chromosome Copy
Number Analysis Tool 4.0 (CNAT 4.0), Affymetrix, which
identifies genome-wide chromosomal gains and losses
and loss of heterozygosity (LOH) [26]. The copy number
state was calculated with a smoothing factor of 0.1 Mb,
compared to a normal population of about 100 individu-
als from the HapMap.
Results
Microsatellite analysis
Parametric linkage analysis, with SimWalk (results in fig-
ure 2), testing both recessive and dominant models,
assuming 80% penetrance and 1–10% phenocopies, did
not identify any LOD higher than 2. The higher peaks
were located at:
￿ Chromosome 1, with a location score of 1.14 at 203.99
cM (1q32.1) with a recessive model;
￿ Chromosome 7, with a location score of 1.04 at 89.95
cM (7q21.11) with a dominant model;BMC Medical Genetics 2008, 9:6 http://www.biomedcentral.com/1471-2350/9/6
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Whole genome linkage analysis with 500 polymorphic microsatellite markers Figure 2
Whole genome linkage analysis with 500 polymorphic microsatellite markers. The results of parametric linkage 
analysis with SimWalk. In blue, the dominant model; in pink, the recessive model.BMC Medical Genetics 2008, 9:6 http://www.biomedcentral.com/1471-2350/9/6
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￿  Chromosome 8, with a location score of 1.3 at
166.47cM (8q24.3) with a dominant model;
￿ Chromosome 13, with a location score of 1.58 at 5.18
cM (13q12.11) and of 1.12 at 100.30 cM (13q33.1) with
a recessive model;
￿ Chromosome 14, with a location score of 1.3 at 65.88
cM (14q23.3) and of 1.34 at 95.71 cM (14q32.12) with a
dominant model;
￿ Chromosome 15, with a location score of 1.8 at 80.43
cM (15q24.3) with a dominant model and of 1.4 at 97.75
cM (15q26.1) with a recessive model; and
￿ Chromosome 17 with a location score of 1.1 at 66.89
cM (17q12) with a dominant model and of 1.54 at 132.67
cM (17q25.3) with a recessive model.
Additional analysis with GENEHUNTER-MODSCORE
[see Additional file 1] shows no significant score and the
higher peaks (between 1.5 and 2) locate to:
￿  Chromosome 3, with a MOD of 1.64 at 12.37 cM
(3p26.02);
￿ Chromosome 4, with a MOD of 1.704 at 204.7 cM
(4q35.2);
￿  Chromosome 13, with a MOD of 1.87 at 4.32 cM
(13q12.11) and of 1.706 at 27.8 cM (13q12.3);
￿ Chromosome 15, with a MOD of 1.95–1.97 between
64.33 cM (15q22.2) and 80.43 (15q24.1) cM;
￿ Chromosome 17, with a MOD of 1.7 between 126.6 cM
(17q25.3) and 132.7 (17q25.3) cM;
￿ Chromosome 18, with a MOD of 1.5 between 82.41 cM
(18q21.32) and 88.85 cM (18q21.33); and
￿ Chromosome 21, with a MOD of 1.6 from 0 cM to 1.53
cM (21q11.2).
The results of the non-parametric linkage analysis with
ALLEGRO revealed no significant LOD score and all LOD
scores were lower than 0.5.
Copy number analysis
No clear cause for the disorder was identified, meaning
that no copy number variant was identified only in the
affected individuals (Results in tables 1 and 2; and Addi-
tional files 2, 3, 4). But rather, several copy number varia-
tions were present in all the family members, with no
pattern of distribution, and irrespective of their affected
status, as compared with a normal population of about
100 individuals from the HapMap project.
Discussion
The present study is a follow-up of a previously report by
Gustavson et al in 1986, who described a large family
from a Northern Swedish isolate with an apparently auto-
somal recessive form of MR [15]. Clinical, biochemical
and genetic examinations have been extensive but incon-
sistent. Large families in geographic isolates, like the one
presented in this report, have represented an important
and powerful tool in genetically mapping inherited disor-
ders [27]. We conducted a series of genetic studies in this
pedigree, aiming to identify a gene responsible for this
form of non-syndromic mental retardation.
Genome wide screen linkage analysis using in 500 poly-
morphic microsatellite markers, showed no significant
LOD scores. Several peaks between 1 and 2 were encoun-
tered using both parametric LOD score analysis, and with
MOD score analysis, particularly at chromosomes 13, 15
and 17, which replicate with two different algorithms (See
additional file 5 to visualise these loci). Copy number
analysis did not reveal a clear genomic cause for the disor-
der, such as a copy number alteration that would be
present only in the affected individuals [28,29]. Instead,
the analysis showed several variants in the family mem-
bers, irrespectively of their affected status. Interestingly, de
Vries et al in 2005 [30] have evidenced that most of the
copy number changes found in patients are familiar; and
therefore thought to be polymorphisms. Indeed, the issue
of deciding whether or not a copy number change is path-
ological or polymorphic can be challenging in complex
traits, such seems to be the case in this form of MR, where
the number of single genes involved can be so high. Fur-
thermore, several lines of evidence have indicated that
copy number variations may be more common in the
population than previously though; and they may repre-
sent normal variants, some of which may influence the
risk to diseases [31,32].
These results suggest that mental retardation in this fam-
ily, unlikely what we were expecting, has a heterogeneous
aetiology. It may be induced by several lower effect genes
variants, probably including copy number variants, which
may affect neurodevelopmental genes known to exist in
the regions indicated by this study. The ability to detect
low risk effect genetic variants requires large samples,
which may be the reason why we didn't find a significant
result.
These results were not totally surprising. It has previously
been demonstrated, in a twin study, that milder forms of
MR have a heritability of about 50%, suggesting that half
of the phenotypic variation of intelligence is explained byBMC Medical Genetics 2008, 9:6 http://www.biomedcentral.com/1471-2350/9/6
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genetic variation [33]. This finding supports the quantita-
tive trait loci (QTLs) hypothesis that mild MR is caused by
the same multiple genes that operate throughout the dis-
tribution of general intelligence. It is possible that many
quantitative trait loci for complex traits such as the general
intelligence are of similarly small effect size [34]. In this
context, Butcher et al in 2005 have identified four risk loci
(at 2q33.3, 18q22.1, 6q25.3 and 7q11.21) [35] and a pos-
sible QTL in the heat-shock cognate protein 8 gene
(HSPA8), on the long arm of chromosome 11 [36], of
modest but significant effect, associated with mild mental
impairment in large cohorts. The authors emphasize that
mild mental retardation should not be assumed to be due
to rare single-gene or chromosomal causes, but rather
caused by the multiple genes that operate throughout the
normal bell-shaped distribution of cognitive ability. Our
results support this hypothesis [37,38].
Conclusion
This report presents a form of MR of complex aetiology in
a large isolated pedigree, where genetic variants may
underlie the risk to this neurodevelopmental disorder.
The geographical isolation may have favoured the
founder effect and the pooling of genetic risk factors in
this population, which is characterized by low genetic var-
iation, as well as the skewing of selective influences.
Unable to identify a gene, this study indicates that the
ascertainment of the cause of MR may be challenging and
that a complex aetiology may be present even in a consan-
guineous family, constituting an additional obstacle for
genetic counselling. Variants in genes involved in molec-
ular mechanisms of cellular plasticity, in genes involved
in the development of underlying neural architectures,
and in genes involved in neurodevelopment and in the
ongoing function of terminally differentiated neurons
may underlie the phenotypic variation of intelligence and
explain instances of intellectual impairment.
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Table 1: Copy number variants encountered in the Northern Swedish family: Aberrations found in the different individuals; several 
copy number variations were present in all the family members, with no pattern of distribution, and irrespective of their affected 
status, as compared with a normal population of about 100 individuals from the HapMap project. Aberrations found only once, and in 
healthy individuals, and aberrations apparently not involved in disease removed were not included.
Individual SEX State A B C D E F G H I J K
301 MM R X X X X
302 M Normal IQ X X X X X
303 MN o r m a l  I Q X
304 FM R X X X
307 M Normal IQ X X X
309 FN o r m a l  I Q X X X X X X
322 FM R X X X X
323 F Normal IQ X X X X X
324 M Normal IQ X X X X X
310 MN o r m a l  I Q X X X X
311 MN o r m a l  I Q X X X X X X
330 MN o r m a l  I Q X X X X X X
829 FM R X X X X X X
830 MM R X X X
319 FM R X X X X X
321 FN o r m a l  I Q X X X X X X X X
u1 MM R X X X X
u2 MM R X X X X X
u3 M M R X X XXXX
329 MM R X X X X
Table 2: Copy number variants encountered in the Northern 
Swedish family: Description of the aberrations. Aberrations 
found only once, and in healthy individuals, and aberrations 
apparently not involved in disease removed were not included.
Aberr. Chrom Pos. [Mb] Signal
A 41 5 4 >  3
B 61 6 1 3
C 81 2 , 4 2 , 5
D 93 1 , 7 2 , 5
E 10 47 2,5
F 11 19 3
G 11 50–55 3
H 14 0–20 2,5
I 14 106 3
J 15 0–20 2,5
K 22 24 2,5BMC Medical Genetics 2008, 9:6 http://www.biomedcentral.com/1471-2350/9/6
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